Los Gatos, CA, United States of America

Scott Borland

USPTO Granted Patents = 12 

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Scott Borland: Innovator in Neuromodulatory Compounds

Introduction

Scott Borland is a prominent inventor based in Los Gatos, CA (US). He has made significant contributions to the field of neuromodulatory compounds, holding a total of 12 patents. His work focuses on developing novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Borland has developed polycyclic compounds and their uses. This invention provides novel neuromodulatory compounds and compositions, along with methods for treating various diseases, disorders, and conditions. Additionally, he has worked on ergoline compounds and their pharmaceutical compositions. These compounds are aimed at treating and preventing medical disorders, such as migraines, and include methods for agonizing and antagonizing specific receptors.

Career Highlights

Scott Borland is currently associated with Xoc Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical field. His research has led to advancements in the treatment of various medical conditions, showcasing his dedication to improving healthcare through innovative solutions.

Collaborations

Throughout his career, Borland has collaborated with notable colleagues, including Thomas A. Armer and Miguel Guzman. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Scott Borland's work in neuromodulatory compounds exemplifies the impact of innovation in medicine. His contributions continue to pave the way for new treatments and therapies, highlighting the importance of research and development in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…